Christine P Petersen1,2, Anne R Meyer1,2, Carlo De Salvo3, Eunyoung Choi2,4,5, Cameron Schlegel2,5, Alec Petersen2, Amy C Engevik2,5, Nripesh Prasad6, Shawn E Levy6, R Stokes Peebles7, Theresa T Pizarro3, James R Goldenring1,2,4,5. 1. Departments of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA. 2. Epithelial Biology Center, Vanderbilt University, Nashville, Tennessee, USA. 3. Department of Pathology, Case Western Reserve School of Medicine, Cleveland, Ohio, USA. 4. Nashville VA Medical Center, Vanderbilt University, Nashville, Tennessee, USA. 5. Department of Surgery, Vanderbilt University, Nashville, Tennessee, USA. 6. HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA. 7. Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Abstract
OBJECTIVE: Alternatively activated macrophages (M2) are associated with the progression of spasmolytic polypeptide-expressing metaplasia (SPEM) in the stomach. However, the precise mechanism(s) and critical mediators that induce SPEM are unknown. DESIGN: To determine candidate genes important in these processes, macrophages from the stomach corpus of mice with SPEM (DMP-777-treated) or advanced SPEM (L635-treated) were isolated and RNA sequenced. Effects on metaplasia development after acute parietal cell loss induced by L635 were evaluated in interleukin (IL)-33, IL-33 receptor (ST2) and IL-13 knockout (KO) mice. RESULTS: Profiling of metaplasia-associated macrophages in the stomach identified an M2a-polarised macrophage population. Expression of IL-33 was significantly upregulated in macrophages associated with advanced SPEM. L635 induced metaplasia in the stomachs of wild-type mice, but not in the stomachs of IL-33 and ST2 KO mice. While IL-5 and IL-9 were not required for metaplasia induction, IL-13 KO mice did not develop metaplasia in response to L635. Administration of IL-13 to ST2 KO mice re-established the induction of metaplasia following acute parietal cell loss. CONCLUSIONS: Metaplasia induction and macrophage polarisation after parietal cell loss is coordinated through a cytokine signalling network of IL-33 and IL-13, linking a combined response to injury by both intrinsic mucosal mechanisms and infiltrating M2 macrophages. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE: Alternatively activated macrophages (M2) are associated with the progression of spasmolytic polypeptide-expressing metaplasia (SPEM) in the stomach. However, the precise mechanism(s) and critical mediators that induce SPEM are unknown. DESIGN: To determine candidate genes important in these processes, macrophages from the stomach corpus of mice with SPEM (DMP-777-treated) or advanced SPEM (L635-treated) were isolated and RNA sequenced. Effects on metaplasia development after acute parietal cell loss induced by L635 were evaluated in interleukin (IL)-33, IL-33 receptor (ST2) and IL-13 knockout (KO) mice. RESULTS: Profiling of metaplasia-associated macrophages in the stomach identified an M2a-polarised macrophage population. Expression of IL-33 was significantly upregulated in macrophages associated with advanced SPEM. L635 induced metaplasia in the stomachs of wild-type mice, but not in the stomachs of IL-33 and ST2 KO mice. While IL-5 and IL-9 were not required for metaplasia induction, IL-13 KO mice did not develop metaplasia in response to L635. Administration of IL-13 to ST2 KO mice re-established the induction of metaplasia following acute parietal cell loss. CONCLUSIONS:Metaplasia induction and macrophage polarisation after parietal cell loss is coordinated through a cytokine signalling network of IL-33 and IL-13, linking a combined response to injury by both intrinsic mucosal mechanisms and infiltrating M2 macrophages. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: M Manocha; M S Shajib; M M Rahman; H Wang; P Rengasamy; M Bogunovic; M Jordana; L Mayer; W I Khan Journal: Mucosal Immunol Date: 2012-07-04 Impact factor: 7.313
Authors: Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney Journal: Proc Natl Acad Sci U S A Date: 2015-04-27 Impact factor: 11.205
Authors: Victoria G Weis; Christine P Petersen; Jason C Mills; Pamela L Tuma; Robert H Whitehead; James R Goldenring Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-09-04 Impact factor: 4.052
Authors: Amy C Engevik; Rui Feng; Eunyoung Choi; Shana White; Nina Bertaux-Skeirik; Jing Li; Maxime M Mahe; Eitaro Aihara; Li Yang; Betsy DiPasquale; Sunghee Oh; Kristen A Engevik; Andrew S Giraud; Marshall H Montrose; Mario Medvedovic; Michael A Helmrath; James R Goldenring; Yana Zavros Journal: Cell Mol Gastroenterol Hepatol Date: 2016-05-17
Authors: Luciana H Osaki; Kevin A Bockerstett; Chun F Wong; Eric L Ford; Blair B Madison; Richard J DiPaolo; Jason C Mills Journal: J Pathol Date: 2019-01-24 Impact factor: 7.996
Authors: Nina Bertaux-Skeirik; Mark Wunderlich; Emma Teal; Jayati Chakrabarti; Jacek Biesiada; Maxime Mahe; Nambirajan Sundaram; Joel Gabre; Jennifer Hawkins; Gao Jian; Amy C Engevik; Li Yang; Jiang Wang; James R Goldenring; Joseph E Qualls; Mario Medvedovic; Michael A Helmrath; Tayyab Diwan; James C Mulloy; Yana Zavros Journal: J Pathol Date: 2017-08 Impact factor: 7.996
Authors: Anne R Meyer; Amy C Engevik; Toni Madorsky; Erika Belmont; Matthew T Stier; Allison E Norlander; Mark A Pilkinton; Wyatt J McDonnell; Jared A Weis; Bogun Jang; Simon A Mallal; R Stokes Peebles; James R Goldenring Journal: Gastroenterology Date: 2020-09-04 Impact factor: 22.682
Authors: Jonathan T Busada; Sivapriya Ramamoorthy; Derek W Cain; Xiaojiang Xu; Donald N Cook; John A Cidlowski Journal: J Clin Invest Date: 2019-02-18 Impact factor: 14.808
Authors: Carlo De Salvo; Luca Pastorelli; Christine P Petersen; Ludovica F Buttò; Kristine-Ann Buela; Sara Omenetti; Silviu A Locovei; Shuvra Ray; Hannah R Friedman; Jacob Duijser; Wei Xin; Abdullah Osme; Fabio Cominelli; Ganapati H Mahabeleshwar; Jason C Mills; James R Goldenring; Theresa T Pizarro Journal: Gastroenterology Date: 2020-10-01 Impact factor: 22.682